Literature DB >> 18276768

Serum prostate-specific antigen levels in men with type 2 diabetes.

Michiaki Fukui1, Muhei Tanaka, Mayuko Kadono, Saeko Imai, Goji Hasegawa, Toshikazu Yoshikawa, Naoto Nakamura.   

Abstract

OBJECTIVE: The aims of this study were to examine if serum prostate-specific antigen (PSA) levels are lower in men with type 2 diabetes compared with those in healthy men and to investigate what factors may be associated with serum PSA levels in men with type 2 diabetes. RESEARCH DESIGN AND METHODS: We compared the serum PSA levels in 224 diabetic men with those in 1,293 healthy men and investigated the relationships between serum PSA levels and various variables.
RESULTS: Except for men aged 40-49 years, serum PSA levels were lower in diabetic men than in healthy men. Multiple regression analysis demonstrated that age, BMI, and presence of diabetes were independent determinants of serum PSA level.
CONCLUSIONS: Serum PSA levels were lower in diabetic men compared with those in healthy men, which is in line with previous reports that patients with type 2 diabetes are at a decreased risk of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18276768     DOI: 10.2337/dc07-1962

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  23 in total

1.  The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted County study.

Authors:  Lauren P Wallner; Hal Morgenstern; Michaela E McGree; Debra J Jacobson; Jennifer L St Sauver; Steven J Jacobsen; Aruna V Sarma
Journal:  Urology       Date:  2010-11-20       Impact factor: 2.649

2.  Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold.

Authors:  Minoru Kobayashi; Tomoya Mizuno; Hideo Yuki; Tsunehito Kambara; Hironori Betsunoh; Akinori Nukui; Hideyuki Abe; Yoshitatsu Fukabori; Masahiro Yashi; Takao Kamai
Journal:  Int J Clin Oncol       Date:  2019-08-22       Impact factor: 3.402

3.  Age-Specific Reference Ranges of Prostate-Specific Antigen among Saudi Men as a Representation of the Arab Population.

Authors:  Danny Munther Rabah; Karim Hamda Farhat; Mohamed Abdullah Al-Atawi; Mostafa Ahmed Arafa
Journal:  Med Princ Pract       Date:  2019-02-07       Impact factor: 1.927

4.  Serum prostate specific antigen changes in cynomolgus monkeys (Macaca fascicularis) on a high sugar high fat diet.

Authors:  James N Mubiru; Magdalena Garcia-Forey; Nicole Cavazos; Peggah Hemmat; Edward J Dick; Michael A Owston; Cassondra A Bauer; Robert E Shade; Jeffrey Rogers
Journal:  Prostate       Date:  2011-06-28       Impact factor: 4.104

Review 5.  Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease.

Authors:  S M Cabarcas; E M Hurt; W L Farrar
Journal:  Curr Mol Med       Date:  2010-11       Impact factor: 2.222

6.  The effect of demographic and clinical factors on the relationship between BMI and PSA levels.

Authors:  Jonathan L Wright; Daniel W Lin; Janet L Stanford
Journal:  Prostate       Date:  2011-03-22       Impact factor: 4.104

7.  Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study.

Authors:  Katharine N Sourbeer; Lauren E Howard; Gerald L Andriole; Daniel M Moreira; Ramiro Castro-Santamaria; Stephen J Freedland; Adriana C Vidal
Journal:  BJU Int       Date:  2014-10-20       Impact factor: 5.588

8.  Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes.

Authors:  Aruna V Sarma; James Hotaling; Rodney L Dunn; Patricia A Cleary; Barbara H Braffett; Catherine Kim; Catherine Martin; William Herman; Patricia Gatcomb; Alan M Jacobson; Sarah K Holt; Hunter Wessells
Journal:  J Urol       Date:  2014-09-11       Impact factor: 7.450

Review 9.  Metabolic Syndrome and Prostate Cancer: a Review of Complex Interplay Amongst Various Endocrine Factors in the Pathophysiology and Progression of Prostate Cancer.

Authors:  Handoo Rhee; Ian Vela; Eric Chung
Journal:  Horm Cancer       Date:  2015-11-06       Impact factor: 3.869

10.  Association of diabetes with prostate cancer risk in the multiethnic cohort.

Authors:  Kevin M Waters; Brian E Henderson; Daniel O Stram; Peggy Wan; Laurence N Kolonel; Christopher A Haiman
Journal:  Am J Epidemiol       Date:  2009-02-24       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.